Drug Approval | October 21, 2021
U.S. FDA gives green light to Moderna and J&J booster doses
The authority also allowed mix and match of booster doses once the primary vaccine has been administered.
The authority also allowed mix and match of booster doses once the primary vaccine has been administered.
By combining Innovaccer's Data Activation Platform with HCL's robust healthcare data accelerator (hDATA) suite, organizations can enable patient-centricity, cost-optimization and compliance
The company operates four mid-sized hospitals with a total bed capacity of 556 in eastern India
The consortium envisages carrying out surveillance of important bacterial, viral and parasitic infections of zoonotic as well as transboundary pathogens
Standalone use of Sputnik Light also provides much higher efficacy against severe disease and hospitalizations
The company plans to raise US $ 15 million
This expansion will support the global operations network and help meet global demand for mammalian development services that support Lonza’s manufacturing sites
An amount of Rs. 70.9 crore has been earmarked for funding capital expenditure for the proposed expansion
VIPER AI solutions support care teams by automating the identification of potentially eligible patients at the time of diagnosis and easily matching them to relevant trials
Gantenerumab is an investigational antibody in Phase III development for early Alzheimer's disease (AD) and a comprehensive data set with an expected readout in mid-2022
Subscribe To Our Newsletter & Stay Updated
